Inhaled glucocorticoids: new developments relevant to updating of the Asthma Management Guidelines
- 31 August 1996
- journal article
- review article
- Published by Elsevier in Respiratory Medicine
- Vol. 90 (7) , 379-384
- https://doi.org/10.1016/s0954-6111(96)90108-0
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- New perspectives on inhaled drug delivery and systemic bioactivity.Thorax, 1995
- Clinical efficacy of budesonide Turbuhaler® compared with that of beclomethasone dipropionate pMDI with volumatic spacerAllergy, 1994
- High-dose inhaled steroids in asthmatics: moderate efficacy gain and suppression of the hypothalamic-pituitary-adrenal (HPA) axis. Research Council of the Norwegian Thoracic SocietyEuropean Respiratory Journal, 1994
- Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthmaJournal of Allergy and Clinical Immunology, 1994
- Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDIEuropean Respiratory Journal, 1994
- A comparison of fluticasone propionate 200 μg/day with beclomethasone dipropionate 400 μg/day in adult asthmaAllergy, 1994
- Inhaled Fluticasone PropionateDrugs, 1994
- Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/day with inhaled beclomethasone dipropionate 400 micrograms/day in mild and moderate asthma.Archives of Disease in Childhood, 1993
- Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group.Thorax, 1993
- Effect of a volumatic spacer and mouth rinsing on systemic absorption of inhaled corticosteroids from a metered dose inhaler and dry powder inhaler.Thorax, 1991